Author:
DePace Nicholas L.,Colombo Joseph
Publisher
Springer International Publishing
Reference171 articles.
1. David JKS, DePace N, Noval J, Reichie FA. Cholesterol lowering mechanism of fish oil rich in ω-3 fatty acids in cardiac patients. Arteriosclerosis. 1987;7(5) :512A.
2. Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2018.
https://doi.org/10.1056/NEJMoa1812792
. [Epub ahead of print].
3. Betteridge DJ. The case for intensive lipid management: The opportunities and issues for cardiologists. PACE-CME Lecture. 2011.
https://pace-cme.org/2011/06/16/the-case-for-intensive-lipid-management-the-opportunities-and-issues-for-cardiologists/
4. Yokoyama M, Origasa H, JELIS Investigators. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). Am Heart J. 2003;146(4):613–20.
5. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolemia patients (JELIS): a randomized open-label, blinded endpoint analysis. Lancet. 2007;369(9567):1090–8. Erratum in: Lancet. 2007 Jul 21;370(9583):220.